5 Most Promising Penny Stocks According to Analysts
Germany-based Affimed N.V. (NASDAQ:AFMD) is working on cancer immunotherapies. Affimed N.V.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Armistice Capital Steven Boyd | 2,506,000 | $5,387,900 | -8% | 0.06% |
2. | 2,708 | $582,220 | +15% | 0.39% | |
3. | 194,900 | $419,035 | +20% | 0% | |
4. | Renaissance Technologies Jim Simons | 77,200 | $165,980 | -72% | 0% |
5. | D E Shaw D. E. Shaw | 45,954 | $98,801 | -58% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.27 | 100,000 | Director | 237,890 | 2019-11-20 | Filing | |
$2.35 | 49,666 | Director | 126,448 | 2018-11-09 | Filing | |
$2.24 | 48,234 | Director | 76,782 | 2018-11-08 | Filing | |
$2.12 | 2,100 | Director | 28,548 | 2018-11-07 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.05 | 24,610 | Officer, Director | 1,977,170 | 2024-06-26 | Filing | |
$2.06 | 13,038 | Officer | 672,186 | 2024-06-26 | Filing | |
$2.06 | 5,894 | Officer, Director | 350,836 | 2024-02-28 | Filing | |
$2.07 | 2,035 | Officer | 145,224 | 2024-02-28 | Filing | |
$1.95 | 4,115 | Officer | 147,259 | 2024-02-01 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 548,308 | $1,255,625 | 0% | |
2. | 173,844 | $398,206 | 0% | |
3. | 166,516 | $381,321 | 0% | |
4. | 163,283 | $373,902 | 0% | |
5. | 95,062 | $217,692 | 0% |